CN Stock MarketDetailed Quotes

688336 Sunshine Guojian Pharmaceutical

Watchlist
  • 21.90
  • -0.07-0.32%
Market Closed Jun 7 15:00 CST
13.51BMarket Cap38.35P/E (TTM)

Sunshine Guojian Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Assets
Current assets
Money funds
-56.26%627.97M
-14.44%933.26M
-20.43%1.21B
-5.20%1.07B
-4.89%1.44B
-32.41%1.09B
-2.24%1.52B
-26.18%1.13B
-31.25%1.51B
-9.24%1.61B
Transactional financial assets
-8.74%889.34M
-59.37%603.87M
-34.68%701.49M
-44.61%749.87M
8.02%974.56M
97.65%1.49B
21.80%1.07B
45.12%1.35B
106.94%902.18M
-19.36%752.05M
Notes receivable and accounts receivable
-4.39%116.16M
-10.79%133.24M
-1.67%136.98M
-2.48%157.54M
-31.81%121.5M
-41.88%149.35M
3.91%139.3M
-33.80%161.55M
199.67%178.17M
149.68%256.97M
-Notes receivable
78.17%3.51M
-0.73%3.48M
20.97%4.8M
-22.92%3.65M
-42.27%1.97M
-6.61%3.5M
-23.57%3.97M
56.84%4.74M
-39.25%3.42M
-65.71%3.75M
-Accounts receivable
-5.76%112.65M
-11.03%129.76M
-2.33%132.18M
-1.87%153.89M
-31.60%119.53M
-42.40%145.85M
5.01%135.33M
-34.93%156.81M
224.63%174.76M
175.31%253.22M
Other receivables (including interest and dividends)
-88.02%135.3K
-31.03%201.39K
-60.52%159.62K
-89.97%55.15K
556.98%1.13M
-44.97%291.99K
48.76%404.28K
122.95%550.16K
-9.04%171.92K
6.73%530.58K
-Other receivable
----
-31.03%201.39K
----
-89.97%55.15K
----
-44.97%291.99K
----
122.95%550.16K
----
6.73%530.58K
Advance payment
2.53%38M
53.57%36.82M
-8.93%26.55M
20.70%26.95M
36.59%37.06M
-9.83%23.97M
-34.03%29.16M
-21.54%22.33M
8.15%27.13M
98.89%26.59M
Inventories
10.91%218.97M
-14.12%194.96M
-26.81%180.67M
-21.05%182.68M
-13.33%197.42M
8.02%227M
0.45%246.86M
2.74%231.39M
-8.92%227.79M
-6.64%210.14M
Other current assets
2,661.29%345.08M
3,954.14%347.46M
8,552.12%241.95M
3,000.41%240.04M
1.10%12.5M
-25.52%8.57M
-80.04%2.8M
-44.20%7.74M
-8.42%12.36M
-83.31%11.51M
Total current assets
-19.58%2.24B
-24.66%2.25B
-17.10%2.5B
-16.47%2.43B
-2.71%2.78B
4.00%2.99B
4.79%3.01B
-2.29%2.91B
-4.11%2.86B
-8.01%2.87B
Non Current assets
Other equity investment
52.56%9.99M
43.99%9.07M
-51.19%5.96M
-57.61%5.65M
-50.85%6.55M
-63.53%6.3M
-39.77%12.22M
-34.32%13.33M
33.19%13.32M
72.68%17.27M
Fixed assets
----
23.30%874.13M
----
-6.28%700.48M
----
-11.23%708.97M
----
-11.65%747.44M
----
-6.28%798.68M
Constru in process
----
-4.09%687.81M
----
31.37%780.18M
----
25.27%717.11M
----
16.76%593.86M
----
31.74%572.47M
Intangible assets
-6.44%236.11M
22.70%240.16M
22.73%244.23M
22.76%248.29M
31.27%252.36M
-0.41%195.73M
-1.29%199M
-2.81%202.25M
-10.43%192.25M
-11.13%196.55M
Development expenditure
11.53%73.52M
-61.02%44.44M
2.66%104.14M
-9.92%89.22M
-33.25%65.92M
16.74%114.02M
16.76%101.44M
16.19%99.04M
20.28%98.76M
22.88%97.67M
Goodwill
0.00%639.6K
0.00%639.58K
0.00%639.58K
0.00%639.58K
0.00%639.58K
0.00%639.58K
0.00%639.58K
0.00%639.58K
0.00%639.58K
0.00%639.58K
Deferred tax assets
-21.97%134.5M
-15.97%145.74M
-6.60%159.27M
-0.02%169.17M
7.18%172.38M
11.67%173.43M
20.27%170.51M
33.30%169.21M
34.80%160.83M
50.52%155.31M
Other non current assets
840.02%1.05B
940.27%965M
431.88%457.58M
549.73%518.45M
43.14%111.96M
26.05%92.76M
81.87%86.03M
71.74%79.79M
95.72%78.22M
107.14%73.59M
Total non current assets
45.29%3.15B
44.66%3.06B
29.46%2.63B
29.49%2.61B
7.86%2.17B
4.70%2.11B
3.18%2.03B
3.11%2.02B
8.99%2.01B
10.10%2.02B
Total assets
8.84%5.38B
4.05%5.31B
1.67%5.13B
2.34%5.04B
1.65%4.95B
4.29%5.1B
4.13%5.04B
-0.15%4.92B
0.90%4.87B
-1.31%4.89B
Liabilities
Current liabilities
Short term loan
-0.04%50.02M
-66.67%50.03M
-66.67%50.03M
0.01%50M
--50.04M
--150.1M
--150.1M
--50M
----
----
Notes payable and accounts payable
22.07%23.9M
37.79%21.93M
-24.15%20.43M
22.48%20.43M
28.67%19.58M
-2.16%15.91M
41.98%26.93M
-14.17%16.68M
-21.49%15.22M
-23.86%16.27M
-Accounts payable
22.07%23.9M
37.79%21.93M
-24.15%20.43M
22.48%20.43M
28.67%19.58M
-2.16%15.91M
41.98%26.93M
-14.17%16.68M
-21.49%15.22M
-23.86%16.27M
Contract liabilities
194.41%39.51M
-14.22%16.77M
64.03%45.34M
-31.29%20.52M
-62.72%13.42M
501.32%19.55M
255.11%27.64M
151.40%29.86M
55.64%36M
-78.91%3.25M
Salaries payable
1.79%25.54M
-9.24%40.97M
-15.21%33.79M
0.58%37.04M
-14.80%25.09M
0.87%45.14M
3.95%39.85M
-14.72%36.83M
-18.14%29.45M
-4.92%44.75M
Taxs payable
2.38%5.9M
-12.64%6.98M
21.62%5.25M
64.81%5.15M
-8.17%5.76M
-4.70%7.99M
2.78%4.32M
-53.93%3.12M
144.95%6.27M
149.38%8.39M
Other payable (including interest and dividends)
84.50%158.08M
25.71%171.46M
-17.28%97.31M
-25.73%91.24M
-24.89%85.68M
-4.48%136.4M
19.30%117.64M
-18.93%122.85M
2.48%114.07M
-26.05%142.79M
-Other payable
----
25.71%171.46M
----
-25.73%91.24M
----
-4.48%136.4M
----
-18.93%122.85M
----
-26.05%142.79M
Total current liabilities
51.80%302.95M
-17.85%308.14M
-31.20%252.15M
-13.48%224.38M
-0.72%199.57M
74.09%375.09M
118.28%366.48M
11.39%259.34M
4.50%201.01M
-23.14%215.45M
Current liabilities
Long term deferred income
-5.44%113.31M
-4.41%118.33M
-4.43%115.75M
-4.61%119.43M
-7.58%119.83M
-7.81%123.79M
-12.81%121.11M
-12.04%125.2M
-12.23%129.66M
-12.30%134.28M
Total non current liabilities
-5.44%113.31M
-4.41%118.33M
-4.43%115.75M
-4.61%119.43M
-7.58%119.83M
-7.81%123.79M
-13.21%121.11M
-12.44%125.2M
-12.23%129.66M
-12.30%134.28M
Total liabilities
30.33%416.25M
-14.51%426.47M
-24.55%367.9M
-10.59%343.81M
-3.41%319.39M
42.65%498.88M
58.60%487.59M
2.33%384.54M
-2.77%330.66M
-19.31%349.73M
Shareholders equity
Paid-in capital
0.00%616.79M
0.00%616.79M
0.00%616.79M
0.00%616.79M
0.09%616.79M
0.09%616.79M
0.09%616.79M
0.09%616.79M
0.00%616.21M
0.00%616.21M
Capital reserve funds
-0.31%2.3B
-0.27%2.3B
0.01%2.31B
0.05%2.31B
0.19%2.31B
0.34%2.31B
0.52%2.31B
0.63%2.31B
1.50%2.31B
1.23%2.3B
Surplus reserve funds
11.48%307.33M
11.48%307.33M
0.00%275.68M
0.00%275.68M
0.00%275.68M
0.00%275.68M
0.00%275.68M
0.00%275.68M
0.00%275.68M
0.00%275.68M
Retained profit
22.13%1.77B
18.58%1.68B
15.51%1.58B
11.13%1.51B
6.04%1.45B
3.61%1.42B
1.00%1.37B
-0.84%1.36B
3.78%1.37B
1.34%1.37B
Other composite income
44.40%-7.78M
18.34%-8.71M
-76.19%-6.12M
56.94%-5.53M
36.54%-14M
38.43%-10.67M
57.81%-3.47M
-52.28%-12.85M
-144.23%-22.06M
-78.95%-17.33M
Shareholders equity without minority interests
7.57%4.99B
6.30%4.9B
4.59%4.78B
3.51%4.71B
2.10%4.64B
1.42%4.61B
0.68%4.57B
-0.02%4.55B
1.58%4.54B
0.85%4.54B
Minority interests
-115.48%-19.94M
-177.96%-17.58M
-59.22%-15.34M
-42.36%-11.92M
-71.05%-9.25M
-156.93%-6.32M
-1,037.38%-9.63M
-223.07%-8.37M
-143.04%-5.41M
-114.23%-2.46M
Total shareholder equity
7.36%4.97B
6.07%4.88B
4.48%4.76B
3.44%4.69B
2.02%4.63B
1.33%4.6B
0.44%4.56B
-0.36%4.54B
1.18%4.54B
0.41%4.54B
Total liabilityies and equity
8.84%5.38B
4.05%5.31B
1.67%5.13B
2.34%5.04B
1.65%4.95B
4.29%5.1B
4.13%5.04B
-0.15%4.92B
0.90%4.87B
-1.31%4.89B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
--
--
Unqualified opinion
--
--
--
--
Auditor
--
--
--
--
--
Ernst & Young (Special General Partnership)
--
--
--
Ernst & Young (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Assets
Current assets
Money funds -56.26%627.97M-14.44%933.26M-20.43%1.21B-5.20%1.07B-4.89%1.44B-32.41%1.09B-2.24%1.52B-26.18%1.13B-31.25%1.51B-9.24%1.61B
Transactional financial assets -8.74%889.34M-59.37%603.87M-34.68%701.49M-44.61%749.87M8.02%974.56M97.65%1.49B21.80%1.07B45.12%1.35B106.94%902.18M-19.36%752.05M
Notes receivable and accounts receivable -4.39%116.16M-10.79%133.24M-1.67%136.98M-2.48%157.54M-31.81%121.5M-41.88%149.35M3.91%139.3M-33.80%161.55M199.67%178.17M149.68%256.97M
-Notes receivable 78.17%3.51M-0.73%3.48M20.97%4.8M-22.92%3.65M-42.27%1.97M-6.61%3.5M-23.57%3.97M56.84%4.74M-39.25%3.42M-65.71%3.75M
-Accounts receivable -5.76%112.65M-11.03%129.76M-2.33%132.18M-1.87%153.89M-31.60%119.53M-42.40%145.85M5.01%135.33M-34.93%156.81M224.63%174.76M175.31%253.22M
Other receivables (including interest and dividends) -88.02%135.3K-31.03%201.39K-60.52%159.62K-89.97%55.15K556.98%1.13M-44.97%291.99K48.76%404.28K122.95%550.16K-9.04%171.92K6.73%530.58K
-Other receivable -----31.03%201.39K-----89.97%55.15K-----44.97%291.99K----122.95%550.16K----6.73%530.58K
Advance payment 2.53%38M53.57%36.82M-8.93%26.55M20.70%26.95M36.59%37.06M-9.83%23.97M-34.03%29.16M-21.54%22.33M8.15%27.13M98.89%26.59M
Inventories 10.91%218.97M-14.12%194.96M-26.81%180.67M-21.05%182.68M-13.33%197.42M8.02%227M0.45%246.86M2.74%231.39M-8.92%227.79M-6.64%210.14M
Other current assets 2,661.29%345.08M3,954.14%347.46M8,552.12%241.95M3,000.41%240.04M1.10%12.5M-25.52%8.57M-80.04%2.8M-44.20%7.74M-8.42%12.36M-83.31%11.51M
Total current assets -19.58%2.24B-24.66%2.25B-17.10%2.5B-16.47%2.43B-2.71%2.78B4.00%2.99B4.79%3.01B-2.29%2.91B-4.11%2.86B-8.01%2.87B
Non Current assets
Other equity investment 52.56%9.99M43.99%9.07M-51.19%5.96M-57.61%5.65M-50.85%6.55M-63.53%6.3M-39.77%12.22M-34.32%13.33M33.19%13.32M72.68%17.27M
Fixed assets ----23.30%874.13M-----6.28%700.48M-----11.23%708.97M-----11.65%747.44M-----6.28%798.68M
Constru in process -----4.09%687.81M----31.37%780.18M----25.27%717.11M----16.76%593.86M----31.74%572.47M
Intangible assets -6.44%236.11M22.70%240.16M22.73%244.23M22.76%248.29M31.27%252.36M-0.41%195.73M-1.29%199M-2.81%202.25M-10.43%192.25M-11.13%196.55M
Development expenditure 11.53%73.52M-61.02%44.44M2.66%104.14M-9.92%89.22M-33.25%65.92M16.74%114.02M16.76%101.44M16.19%99.04M20.28%98.76M22.88%97.67M
Goodwill 0.00%639.6K0.00%639.58K0.00%639.58K0.00%639.58K0.00%639.58K0.00%639.58K0.00%639.58K0.00%639.58K0.00%639.58K0.00%639.58K
Deferred tax assets -21.97%134.5M-15.97%145.74M-6.60%159.27M-0.02%169.17M7.18%172.38M11.67%173.43M20.27%170.51M33.30%169.21M34.80%160.83M50.52%155.31M
Other non current assets 840.02%1.05B940.27%965M431.88%457.58M549.73%518.45M43.14%111.96M26.05%92.76M81.87%86.03M71.74%79.79M95.72%78.22M107.14%73.59M
Total non current assets 45.29%3.15B44.66%3.06B29.46%2.63B29.49%2.61B7.86%2.17B4.70%2.11B3.18%2.03B3.11%2.02B8.99%2.01B10.10%2.02B
Total assets 8.84%5.38B4.05%5.31B1.67%5.13B2.34%5.04B1.65%4.95B4.29%5.1B4.13%5.04B-0.15%4.92B0.90%4.87B-1.31%4.89B
Liabilities
Current liabilities
Short term loan -0.04%50.02M-66.67%50.03M-66.67%50.03M0.01%50M--50.04M--150.1M--150.1M--50M--------
Notes payable and accounts payable 22.07%23.9M37.79%21.93M-24.15%20.43M22.48%20.43M28.67%19.58M-2.16%15.91M41.98%26.93M-14.17%16.68M-21.49%15.22M-23.86%16.27M
-Accounts payable 22.07%23.9M37.79%21.93M-24.15%20.43M22.48%20.43M28.67%19.58M-2.16%15.91M41.98%26.93M-14.17%16.68M-21.49%15.22M-23.86%16.27M
Contract liabilities 194.41%39.51M-14.22%16.77M64.03%45.34M-31.29%20.52M-62.72%13.42M501.32%19.55M255.11%27.64M151.40%29.86M55.64%36M-78.91%3.25M
Salaries payable 1.79%25.54M-9.24%40.97M-15.21%33.79M0.58%37.04M-14.80%25.09M0.87%45.14M3.95%39.85M-14.72%36.83M-18.14%29.45M-4.92%44.75M
Taxs payable 2.38%5.9M-12.64%6.98M21.62%5.25M64.81%5.15M-8.17%5.76M-4.70%7.99M2.78%4.32M-53.93%3.12M144.95%6.27M149.38%8.39M
Other payable (including interest and dividends) 84.50%158.08M25.71%171.46M-17.28%97.31M-25.73%91.24M-24.89%85.68M-4.48%136.4M19.30%117.64M-18.93%122.85M2.48%114.07M-26.05%142.79M
-Other payable ----25.71%171.46M-----25.73%91.24M-----4.48%136.4M-----18.93%122.85M-----26.05%142.79M
Total current liabilities 51.80%302.95M-17.85%308.14M-31.20%252.15M-13.48%224.38M-0.72%199.57M74.09%375.09M118.28%366.48M11.39%259.34M4.50%201.01M-23.14%215.45M
Current liabilities
Long term deferred income -5.44%113.31M-4.41%118.33M-4.43%115.75M-4.61%119.43M-7.58%119.83M-7.81%123.79M-12.81%121.11M-12.04%125.2M-12.23%129.66M-12.30%134.28M
Total non current liabilities -5.44%113.31M-4.41%118.33M-4.43%115.75M-4.61%119.43M-7.58%119.83M-7.81%123.79M-13.21%121.11M-12.44%125.2M-12.23%129.66M-12.30%134.28M
Total liabilities 30.33%416.25M-14.51%426.47M-24.55%367.9M-10.59%343.81M-3.41%319.39M42.65%498.88M58.60%487.59M2.33%384.54M-2.77%330.66M-19.31%349.73M
Shareholders equity
Paid-in capital 0.00%616.79M0.00%616.79M0.00%616.79M0.00%616.79M0.09%616.79M0.09%616.79M0.09%616.79M0.09%616.79M0.00%616.21M0.00%616.21M
Capital reserve funds -0.31%2.3B-0.27%2.3B0.01%2.31B0.05%2.31B0.19%2.31B0.34%2.31B0.52%2.31B0.63%2.31B1.50%2.31B1.23%2.3B
Surplus reserve funds 11.48%307.33M11.48%307.33M0.00%275.68M0.00%275.68M0.00%275.68M0.00%275.68M0.00%275.68M0.00%275.68M0.00%275.68M0.00%275.68M
Retained profit 22.13%1.77B18.58%1.68B15.51%1.58B11.13%1.51B6.04%1.45B3.61%1.42B1.00%1.37B-0.84%1.36B3.78%1.37B1.34%1.37B
Other composite income 44.40%-7.78M18.34%-8.71M-76.19%-6.12M56.94%-5.53M36.54%-14M38.43%-10.67M57.81%-3.47M-52.28%-12.85M-144.23%-22.06M-78.95%-17.33M
Shareholders equity without minority interests 7.57%4.99B6.30%4.9B4.59%4.78B3.51%4.71B2.10%4.64B1.42%4.61B0.68%4.57B-0.02%4.55B1.58%4.54B0.85%4.54B
Minority interests -115.48%-19.94M-177.96%-17.58M-59.22%-15.34M-42.36%-11.92M-71.05%-9.25M-156.93%-6.32M-1,037.38%-9.63M-223.07%-8.37M-143.04%-5.41M-114.23%-2.46M
Total shareholder equity 7.36%4.97B6.07%4.88B4.48%4.76B3.44%4.69B2.02%4.63B1.33%4.6B0.44%4.56B-0.36%4.54B1.18%4.54B0.41%4.54B
Total liabilityies and equity 8.84%5.38B4.05%5.31B1.67%5.13B2.34%5.04B1.65%4.95B4.29%5.1B4.13%5.04B-0.15%4.92B0.90%4.87B-1.31%4.89B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----------Unqualified opinion--------
Auditor ----------Ernst & Young (Special General Partnership)------Ernst & Young (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg